IMS Health raises $1.3B in NY IPO

Share this article:
IMS to go public, says aquisitions possible
IMS Health raises $1.3 billion in its New York IPO.

IMS Health raised $1.3 billion last month in its New York IPO. The company, which analysts expected would see shares go for between $18 and $21, sold 65 million shares at $20, according to VentureBeat.com.

Formerly public, IMS went private in 2010, after TPG Capital, Canada Pension Plan Investment Board (CPPIB) and Leonard Green & Partners bought it for $5.2 billion, including debt. After the offering, TPG's stake was set to be cut 50% from 62.2%, without underwriters exercising their full option.

The Danbury, CT-based company said it plans to use the offering's net proceeds for debt financing and general corporate purposes.

IMS's operating income rose to $276 million in the nine months ended September 30, 2013, from $173 million a year earlier. Revenue rose 4% to $1.9 billion.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.